Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
Season

26:44
April 19, 2025 - PBS News Weekend full episode

57:46
April 18, 2025 - PBS News Hour full episode

57:46
April 17, 2025 - PBS News Hour full episode

57:46
April 16, 2025 - PBS News Hour full episode

57:46
April 15, 2025 - PBS News Hour full episode

57:46
April 14, 2025 - PBS News Hour full episode

26:44
April 13, 2025 - PBS News Weekend full episode

26:45
April 12, 2025 - PBS News Weekend full episode

57:46
April 11, 2025 - PBS News Hour full episode

57:46
April 10, 2025 - PBS News Hour full episode

57:46
April 9, 2025 - PBS News Hour full episode

57:46
April 8, 2025 - PBS News Hour full episode